Several new tick-borne viruses have been discovered in various parts of the world in the past 10 years. The latest may be a previously unknown orthonairovirus known as Wetland virus (WELV).
Risultati per: Trattamento domiciliare di un paziente positivo al virus SARS-Cov-2
Questo è quello che abbiamo trovato per te
Prognosis of Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2, or Conventional Etiologies
This cohort study examines cardiovascular complications of postvaccine and other types of myocarditis (ie, post–COVID-19 and conventional myocarditis) during 18-month follow-up.
Primo trapianto di viso e intero occhio, il paziente fa progressi
Mantenuta la vitalità dell’occhio. Una nuova tecnica punta al recupero della vista
Da novembre ai neonati l'anticorpo contro il virus sinciziale
Il via libera in conferenza Stato-Regioni, stanziati 50 milioni
Virus respiratori e anziani, “serve un'adeguata copertura vaccinale”
Italia Longeva, anche una banale influenza può essere letale
Papilloma virus, da gennaio vaccinazione estesa alle farmacie
Saltamartini: Diamo attuazione a Piano Socio Sanitario Regionale
Papilloma virus, da gennaio vaccinazione estesa alle farmacie
Saltamartini: Diamo attuazione a Piano Socio Sanitario Regionale
Hiv, nel latte materno solo tracce di virus inattivo e non integro
Nelle donne Hiv-positive ma con la carica virale bassa
Le indicazioni dell'Iss al ministero: 'Il farmaco per il virus sinciziale non sia a tappeto'
L’Istituto in una nota, ‘modesta riduzione dell’ospedalizzazione’
Nuova opzione di trattamento per la sclerosi multipla
>>>ANSA/ Sos Regioni su virus sinciziale, il farmaco non basta
Lettera ad Aifa e Ministero.Sanofi, “c’è per il 75% dei bimbi”
>>>ANSA/ Sos Regioni su virus sinciziale, il farmaco non basta
Lettera ad Aifa e Ministero.Ipotesi modifica calendario vaccini
Sos Regioni su virus sinciziale, 'farmaco non basta per tutti'
Lettera ad Aifa e Ministero, ‘scenario di grave sperequazione’
Using digital tools and antigen rapid testing to support household-level SARS-CoV-2 detection by community health workers in Rwanda: an operational pilot study
Objective
To evaluate the use of antigen-based rapid diagnostic tests (Ag-RDTs) alongside a digital tool to deliver household-level COVID-19 testing by community health workers (CHWs), in line with Rwanda’s ambition to decentralise COVID-19 testing.
Design
This was an operational pilot study to evaluate the impact and operational characteristics of using the digital e-ASCov tool combined with Ag-RDTs to support COVID-19 symptom screening and rapid testing by CHWs across eight districts in Rwanda. A total of 800 CHWs selected from both rural and urban areas were trained in delivering Ag-RDTs for COVID-19 testing and using the e-ASCOV application for data capture on a smartphone. Laboratory technicians repeated a subset of Ag-RDTs to assess the concordance of results obtained by CHWs. The study also assessed CHWs’ experience of the intervention using a mixed-methods approach.
Setting
Eight rural, urban and semiurban districts in Rwanda.
Participants
A total of 19 544 individuals were enrolled and screened for signs and symptoms of COVID-19.
Interventions
Community-based screening for COVID-19 by CHWs using the digital tool e-ASCov combined with rapid testing using Ag-RDTs.
Main outcome measures
Number of participants screened and tested; concordance of Ag-RDT results between CHWs and laboratory technicians; feasibility of study procedures by CHWs and CHWs perceptions of the digital tool and Ag-RDT testing.
Results
From February to May 2022, CHWs screened 19 544 participants, of whom 4575 (23.4%) had COVID-19-related symptoms or a history of exposure to the infection. Among them, 86 (1.9%) were positive on Ag-RDTs. Concordance of Ag-RDT results between CHWs and laboratory technicians was 100%. Of the 800 trained CHWs, 746 (93.3%) were independently able to conduct household-based COVID-19 screening, perform the Ag-RDTs and send data to the central server. Most CHWs ( >80%) found Ag-RDTs and e-ASCOV easy to use.
Conclusions
This study demonstrated the feasibility of deploying a digital tool and Ag-RDTs for household-level SARS-CoV-2 detection in Rwanda. The findings support a broader roll-out of digitally supported rapid testing by CHWs to broaden access to testing for priority diseases.
Luce tra i frammenti,un corto narra il percorso del paziente
Promosso da Gilead e dedicato all’innovazione Car-T
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection
New England Journal of Medicine, Volume 391, Issue 12, Page 1096-1107, September 26, 2024.